The J.P. Morgan View Growth versus virus now, vaccine versus virus later –an update on a conflict and a hope Cross-asset strategy: The dominant macro narrative of the past several weeks hasn’t changed much, and neither has the pattern of uneven advances across and within global markets. The reality of a booming economy versus the threat of a spending retrenchment…
The US equity market continues to ride the wave of liquidity and seasonal FOMO. As we approach our bull...
BofA Merrill Lynch 2019 Market Outlook: From Peak to Trough, the Market Unfriends Stocks and Bonds, Likes Volatility, and...
And oh what a week it was… if you went into the week under the impression that new S&P...
In the following video, Wayne Nelson discusses the Technology Select Spider ETF (XLK). He offers some technical analysis that...
The market fell last week and snapped a 3-week win streak after the major indices danced around record highs....
Larger narrative is Fed “disinflation” is a massive course correction. Strong Jan equity returns borrowing from Feb, but dip...
After last week’s inflation and jobs reports, the debate rages on about what the Fed will do with interest...
Did The Fed Already Pull It Off To watch our State of the Market Heading Into 2H 2024 video,...
JPM Market Recap
$0.00
JPM Research Note
$0.00
JP Morgan Market Volatility Report
$0.00
MarketWatch.com – Top Stories
